International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Mol Clin Oncol 14:[Related article:] Article no. 8, 2021; DOI: 10.3892/mco.2020.2170
Following the publication of this article, the authors have requested that the first sentence in the Materials and methods section, as it appeared towards the bottom of the left-hand column of the second page, be amended as follows (essentially, the dates have been revised, as indicated in bold): “A total of 136 consecutive patients with primary epithelial ovarian cancer and existing pretreatment CA125 levels .500 U/ml and CA125 <500 U/ml at the time of surgery treated at the department of obstetrics and gynecology from January 2000 through June 2007 at University Tübingen, Germany were enrolled in the study and retrospectively analyzed.”
The authors regret that this error went unnoticed before the publication of the article, and all authors agree with publishing this Corrigendum; moreover, this change does not affect any of the major conclusions reported in the study. The authors are grateful to the Editor of Molecular and Clinical Oncology for allowing them the opportunity to publish this Corrigendum, and apologize to the readership of the Journal for any inconvenience caused.